Jeff Yass’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$222K Sell
35,700
-12,000
-25% -$69.4K ﹤0.01% 11691
2026
Q2
$290K Buy
47,700
+13,900
+41% +$334K ﹤0.01% 11117
2026
Q1
$860K Buy
33,800
+7,400
+28% +$209K ﹤0.01% 8278
2025
Q4
$554K Sell
26,400
-15,000
-36% -$244K ﹤0.01% 8531
2025
Q3
$640K Buy
+41,400
New +$594K ﹤0.01% 8409

Other funds holding RGC

Jeff Yass's RGC Position: Q3 2026 in Review

Jeff Yass increased its Regencell Bioscience (RGC) stake by 86% in Q3 2026, buying an estimated $115K and bringing the position to 43,075 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #11236.

Jeff Yass first reported a position in RGC in Q2 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • Jeff Yass held 43,075 shares of Regencell Bioscience worth $268K as of Q3 2026.
  • Jeff Yass bought 19,946 Regencell Bioscience shares in Q3 2026, an estimated $115K.
  • Regencell Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11236 holding.
  • Jeff Yass first reported a position in Regencell Bioscience in Q2 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.